• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses

tetano

Editor, Senior Moderator
Vaccine


. 2025 Jul 4:62:127449.
doi: 10.1016/j.vaccine.2025.127449. Online ahead of print. Self-amplifying mRNA expressing COBRA hemagglutinin elicits long-lasting, broadly reactive antibodies against seasonal influenza A viruses

Spencer R Pierce[SUP] 1 [/SUP], Hua Shi[SUP] 2 [/SUP], Camila Caetano[SUP] 3 [/SUP], David A Prots[SUP] 3 [/SUP], Michael A Carlock[SUP] 1 [/SUP], Audrey M Cervantes[SUP] 4 [/SUP], Brian L Hua[SUP] 4 [/SUP], Amy R Rappaport[SUP] 4 [/SUP], Heather Larson[SUP] 4 [/SUP], Ciaran D Scallan[SUP] 4 [/SUP], Karin Jooss[SUP] 4 [/SUP], Ted M Ross[SUP] 5 [/SUP]



Affiliations
Abstract

Development of universal or broadly-reactive influenza virus vaccines is critical for addressing emerging pandemic strains, as well as improving the effectiveness and longevity of annual, seasonal influenza virus vaccines. The next generation of influenza vaccines need to address expanding the breadth of vaccine induced immune response to neutralize drifted variants, enhance the longevity of elicited immunity, and preferably use single-shot platforms that will reduce the number of vaccinations and expand the number of doses available. In this report, influenza hemagglutinin sequences, developed using computationally optimized broadly-reactive antigen (COBRA) methodology, were expressed from a self-amplifying mRNA (samRNA) vector to elicit broadly-reactive, protective immunity following a single vaccination of mice or ferrets. Three COBRA HA antigens representing an H1 HA (Y2) or two H3 HA (J4 or NG2) were expressed from individual samRNA vectors and administered individually or mixed as H1/H3 HA samRNA vaccines. In addition, two HA antigens were expressed from the same vector (Y2-J4 or Y2-NG2) as a dual expressing samRNA vaccine. Mice or ferrets vaccinated with these samRNA vaccines had long-lasting antibodies with hemagglutination-inhibition activity against a panel of H1N1 and H3N2 influenza strains representing past, current, and future drifted influenza virus variants. In addition, samRNA expressed COBRA HA antigens elicited H1 and H3 specific T cell resposnes against HA head and stem regions. Animals challenged with H1N1 or H3N2 influenza viruses had little weight loss or signs of morbidity and little to no virus detected in the lungs or nasal washes following challenge. Overall, samRNA vectors, expressing COBRA HA antigens, efficiency elicited broadly-reactive and protective immune responses following a single vaccination.

Keywords: Ferrets; Hemagglutinin; Influenza; Mice; Vaccine; samRNA.

 
Back
Top Bottom